Brisbane-based AI and ML specialist consultancy Max Kelsen has secured a trial for its new data platform with Peter MacCallum Cancer Centre (Peter Mac).
/PRNewswire/ BridGene Biosciences, Inc., a biotechnology company using a unique chemoproteomic technology to discover and develop small molecules for high.